The Patent Finder

Recro Pharma, Inc.

Also on record
Records under this name other than patents Recro Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Recro Pharma, Inc.

PatentTitleStatus Expires Confidence
US 10,881,663Method of Treating Pain in Elderly Patients with Mild Renal Impairment
In force
 · High confidence
In forceHigh confidence
US 11,458,145Methods of Administering Intravenous Meloxicam in a Bolus Dose
In force
 · High confidence
In forceHigh confidence
US 9,795,559Intranasal Dexmedetomidine Compositions and Methods of Use Thereof
now held by Baudax Bio, Inc.
Lapsed on the fee record
Ended Oct 24, 2025 · High confidence
Lapsed on the fee recordEnded Oct 24, 2025High confidence
US 8,512,727Nanoparticulate meloxicam formulations
Lapsed on the fee record
Ended Aug 20, 2025 · High confidence
Lapsed on the fee recordEnded Aug 20, 2025High confidence
US 7,759,496Imidazol Derivatives Having Affinity for Alpha 2 Receptors Activity
now held by Baudax Bio, Inc.
Term ended
Term ended Apr 10, 2025 · High confidence
Term endedTerm ended Apr 10, 2025High confidence
US 8,323,641Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Lapsed on the fee record
Ended Dec 4, 2024 · High confidence
Lapsed on the fee recordEnded Dec 4, 2024High confidence
US 10,682,311Intranasal Dexmedetomidine Compositions And Methods Of Use Thereof
now held by Baudax Bio, Inc.
Lapsed on the fee record
Ended Jun 16, 2024 · High confidence
Lapsed on the fee recordEnded Jun 16, 2024High confidence
US 10,463,673Nanoparticulate Meloxicam Formulations
Term ended
Term ended Feb 24, 2024 · Medium confidence
Term endedTerm ended Feb 24, 2024Medium confidence
US 10,471,067Nanoparticulate Meloxicam Formulations
Term ended
Term ended Feb 24, 2024 · Medium confidence
Term endedTerm ended Feb 24, 2024Medium confidence
US 10,709,713Nanoparticulate Meloxicam Formulations
Term ended
Term ended Feb 24, 2024 · Medium confidence
Term endedTerm ended Feb 24, 2024Medium confidence
10 of 20 records shown.
Pro members see all 20.
Pro members: see all 20 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited